Risk of renal cancer in patients with inflammatory bowel disease: A pooled analysis of population-based studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of renal cancer in patients with inflammatory bowel disease: A pooled analysis of population-based studies

Published:2021-02 Issue:2 Volume:39 Page:93-99
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Feng Dechao,Bai Yunjin,Liu Shengzhuo,Yang Yubo,Han Ping,Wei Wuran

Funder

Department of Science and Technology of Sichuan Province

West China Hospital, Sichuan University

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The epidemiology and risk factors for renal cancer;Qayyum;Curr Urol,2013

3. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012

4. Epidemiology: rising in the east;Chi;Nature,2016

5. Cancer risk in patients with inflammatory bowel disease: a population-based study;Bernstein;Cancer,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota;Frontiers in Immunology;2024-01-15

2. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis;Colorectal Cancer;2024

3. Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers;Frontiers in Genetics;2023-12-21

4. The Risk and Predictors of Malignancies in Ankylosing Spondylitis Patients in Israel—A Retrospective Electronic Data-Based Study;Journal of Clinical Medicine;2023-08-07

5. Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium;Aging and disease;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3